3rd Annual MDA Insights in Research Investor Summit (IRIS) for Neuromuscular Disease

The purpose of IRIS is to provide an opportunity for companies and inventors in the neuromuscular space to showcase investment and licensing opportunities to BD teams from biotechnology and pharma and venture investors. Throughout the day, a select group of presenters, ranging from inventors to early-stage biotech and pharmaceutical companies, will have the opportunity to present in 20-minute sessions, with time set aside for Q&A after the presentation. Potential investors will have the opportunity to ask questions during the session and to connect with presenters afterwards at designated break-out areas.

Please see our IRIS Agenda here

IRIS Compendium

Want to attend IRIS? Please register to attend the MDA Conference

Questions/Inquires – Contact Elizabeth Habeeb-Louks